News

Filter

Current filters:

Elan Drug Technologies

Alkermes completes Elan DT buy; signs manufacturing deal

19-09-2011

US drugmaker Alkermes (Nasdaq: ALKS) says it has now completed its previously-announced acquisition of…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsPharmaceutical

Alkermes shareholders vote in favor of merger with Elan Drug Technology

09-09-2011

Shareholders of USA-based Alkermes (Nasdaq; ALKS) have voted to approve the previously-announced $960…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsPharmaceutical

Elan Drug Tech to merge into Alkermes in $960 million deal to create CNS leader

09-05-2011

US drugmaker Alkermes (Nasdaq: ALKS) and Ireland-based Elan Corp (NYSE: ELN) revealed this morning that…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsNeurologicalPharmaceutical

Elan plans to retire $500 million of debt; says time not right to sell EDT; updates on Alzheimer’s drug

10-08-2010

Irish drugmaker Elan Corp announced this morning that it will retire up to $500 million in outstanding…

ElanElan Drug TechnologiesFinancialNeurologicalPharmaceuticalResearch

Elan again mulls hiving off its drug delivery business as separate unit; chairman to retire

20-04-2010

Having previously failed to do so in 2008, Ireland-based drugmaker Elan Corp says it is again exploring…

Elan Drug TechnologiesFinancialMergers & AcquisitionsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top